CTOs on the Move

Fruition Partners

www.fruitionpartners.com

 
Fruition Partners is the service management partner of the world`s leading organizations. We`re a global technology-enabled services firm dedicated to helping organizations improve efficiency and lower costs by elevating service management to the cloud. From robust service offerings to innovative solutions, we have the technology-enabled tools and services to help organizations attain sustainable success throughout the service management process. As the only ServiceNow Master Solutions Partner dedicated to the ServiceNow platform, we ensure our customers experience the benefits of cloud-based service management quickly and easily.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

BrandMaker

BrandMaker offers enterprise solutions for your marketing needs. Our software and services can help your company thrive in a competitive landscape. Learn more.

Alpha Software

At Alpha Software our mission is to build cutting edge database software that enables our customers to build breakthrough applications and solve database management problems rapidly and easily.

Best It.com, Inc.

Best It.com, Inc. is one of the leading providers in Software and Internet. It is based in Phoenix, AZ. To find more information about Best It.com, Inc., please visit www.bestit.com.

OLB.com

OLB.com is a New York, NY-based company in the Software and Internet sector.

Kapost

Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.